Showing results 1 to 1 of 1
Combination of a STAT3 inhibitor with anti-PD-1 immunotherapy is an effective treatment regimen for a vemurafenib-resistant melanoma Kim, Tae Woo; Kim, Yujin; Keum, Hyeongseop; Jung, Wonsik; Kang, Minho; Jon, Sangyong, MOLECULAR THERAPY-ONCOLYTICS, v.26, pp.1 - 14, 2022-09 |
Discover